Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.

Saved in:
Bibliographic Details
Title: Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.
Authors: Roy AM; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Jiang C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Perimbeti S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Deng L; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Shapiro CL; Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Gandhi S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Source: Cancers [Cancers (Basel)] 2023 Aug 25; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first